Anticancer drug resistance: An update and perspective is a research paper published in Drug Resistance Updates (2021). On theSindex it has a DataRank of 0.891. It has been cited 379 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.891
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Intramural NIH HHS
Grant: Z01 BC010441
NCI NIH HHS
Grant: HHSN261201500003C
National Institutes of Health
Grant: HHSN261201500003I
Frederick National Laboratory for Cancer Research
National Cancer Institute
MeSH Terms
Keywords